Interventional cardiology in a whole new light

Open menu

News & Events

Opsens named to the TSX Venture Top 50

12 February 2014

QUEBEC, QUEBEC, February 12, 2014. Opsens Inc. (TSXV:OPS) (the “Company” or “Opsens”) was today named a 2014 TSX Venture 50® company by the TMX Group. The TSX Venture 50® ranks the top 10 companies in five major industry sectors, identifying emerging companies that have shown strong results in key measures of market performance. Opsens was…

Read more

Opsens announces financing details

3 February 2014

QUÉBEC, QUÉBEC, February 3, 2014. Opsens Inc. (TSX-V:OPS) (the “Company” or “Opsens”) is pleased to announce that in connection with its previously announced public offering, it has entered into an underwriting agreement with a syndicate of underwriters led by RBC Capital Markets and including Paradigm Capital Inc. (collectively, the “Underwriters”) to sell 6,164,300 common shares…

Read more